Month: <span>November 2024</span>
Month: November 2024

Month: November 2024

Child And Adolescent Mental Health

“Short” Versus “Long” Duration of Untreated Psychosis in People with First-Episode Psychosis: A Systematic Review and Meta-Analysis of Baseline Status and Follow-Up Outcomes

Schizophr Bull. 2024 Nov 24:sbae201. doi: 10.1093/schbul/sbae201. Online ahead of print. ABSTRACT BACKGROUND AND HYPOTHESIS: Duration of untreated psychosis (DUP) has been linked to worse …

Paediatrics

Disconnect to Reconnect: Practical Approaches to Managing Social Media’s Impact on Pediatric Mental Health

J Pediatr Health Care. 2024 Nov 23:S0891-5245(24)00302-X. doi: 10.1016/j.pedhc.2024.10.005. Online ahead of print. ABSTRACT INTRODUCTION: The pediatric mental health crisis has intensified, especially during the …

Paediatrics

Examining Interventions for Pediatric Adverse Childhood Experiences in an Integrated Primary Care Setting

J Pediatr Health Care. 2024 Nov 22:S0891-5245(24)00318-3. doi: 10.1016/j.pedhc.2024.10.015. Online ahead of print. ABSTRACT INTRODUCTION: Adverse Childhood Experiences (ACEs) increase the risk of chronic diseases …

Paediatrics

Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeutics

Cytotherapy. 2024 Oct 29:S1465-3249(24)00903-4. doi: 10.1016/j.jcyt.2024.10.008. Online ahead of print. ABSTRACT BACKGROUND AIMS: Despite promising results in pre-clinical studies, mesenchymal stromal cells (MSCs) face significant …

Paediatrics

The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology

J Allergy Clin Immunol. 2024 Nov 22:S0091-6749(24)01177-1. doi: 10.1016/j.jaci.2024.09.031. Online ahead of print. ABSTRACT Omalizumab was recently approved by the US Food and Drug Administration …